Jeremy C Jones

13PUBLICATIONS
31CO-AUTHORS
Animal protection (incl. pests and pathogens)Disease surveillanceAnimal growth and developmentMedical infection agents (incl. prions)Fish pests and diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 19, 2026
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.

Konstantin Andreev, Jeremy C Jones, Ahmed Kandeil

|Feb 18, 2026
Baloxavir alleviates severe disease and viremia in ferrets infected with avian- or bovine-origin influenza A(H5N1) virus.

Jeremy C Jones, Konstantin Andreev, Vyoma Sheth

|Oct 16, 2025
Laboratory Methods for Monitoring Influenza Antiviral Resistance.

Emi Takashita, Cameron R Wolfe, Jeremy C Jones

|Jul 22, 2025
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like properties.

Thomas P Fabrizio, Ahmed Kandeil, Walter N Harrington

|Mar 28, 2025
Publisher Correction: Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milk.

Jeremy C Jones, Konstantin Andreev, Thomas P Fabrizio

|Mar 18, 2025
Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milk.

Jeremy C Jones, Konstantin Andreev, Thomas P Fabrizio

Pageof 3

Frequent Collaborators

9 joint publications

Elena A Govorkova

9 joint publications

Richard J Webby

6 joint publications

Konstantin Andreev

5 joint publications

Ahmed Kandeil